Q1 2017 13F Holders as of 31 Mar 2017
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
194M
-
Number of holders
-
502
-
Total 13F shares, excl. options
-
190M
-
Shares change
-
+27.4M
-
Total reported value, excl. options
-
$25.5B
-
Value change
-
+$3.7B
-
Put/Call ratio
-
0.93
-
Number of buys
-
280
-
Number of sells
-
-197
-
Price
-
$133.67
Significant Holders of INCYTE CORP - COMMON STOCK (INCY) as of Q1 2017
578 filings reported holding INCY - INCYTE CORP - COMMON STOCK as of Q1 2017.
INCYTE CORP - COMMON STOCK (INCY) has 502 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 190M shares
of 194M outstanding shares and own 98.39% of the company stock.
Largest 10 shareholders include BAKER BROS. ADVISORS LP (34.1M shares), VANGUARD GROUP INC (15.4M shares), WELLINGTON MANAGEMENT GROUP LLP (13.8M shares), BlackRock Inc. (13.4M shares), PRICE T ROWE ASSOCIATES INC /MD/ (9.21M shares), STATE STREET CORP (7.58M shares), Capital World Investors (7.44M shares), Capital International Investors (6.16M shares), SANDS CAPITAL MANAGEMENT, LLC (4.25M shares), and BB BIOTECH AG (3.49M shares).
This table shows the top 502 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.